Bone regeneration after topical BMP-2-gene delivery in circumferential peri-implant bone defects

Clin Oral Implants Res. 2008 Jun;19(6):590-9. doi: 10.1111/j.1600-0501.2007.01526.x. Epub 2008 Apr 16.

Abstract

Objectives: The aims of this study were to evaluate the rate of bone formation and osseointegration after topical gene delivery with a liposomal vector system carrying bone morphogenetic protein (BMP)-2 cDNA in combination with a collagen carrier and autologous bone as a carrier in freshly created peri-implant bone defects.

Materials and methods: Eight domestic pigs received nine calvariae defects each (10 x 7 mm). A dental implant was inserted into the centre of each defect. In the test groups, the remaining space was filled with the liposomal vector/BMP-2 complex combined with a collagen carrier (n=18) or an autologous bone graft (n=18). Control groups were collagen only (n=18) and autologous bone graft only (n=18).

Results: There was a significant difference in mineralisation rate in the BMP-2/bone graft (29.9%+/- 4.8 and 68.3%+/- 7.2) and bone graft only (22.6%+/- 2.6 and 49.4%+/- 13.9) groups after 7 and 28 days. Mineralisation values were also significantly higher in the BMP-2/collagen group (21.2%+/- 16.2 and 53.1%+/- 12.5) compared with the collagen-only group (8.2%+/- 7 and 41%+/- 8.1) in two different regions after 28 days. Also the bone-to-implant contact was significantly increased in the BMP-2/bone graft group after 28 days and in the BMP-2/collagen group after 7 and 28 days compared with their control groups.

Conclusions: The results of this study show a significantly positive effect of liposomal vector/BMP-2 on bone regeneration and osseointegration in bony circumferential peri-implant defects.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bone Morphogenetic Protein 2
  • Bone Morphogenetic Proteins / administration & dosage*
  • Bone Morphogenetic Proteins / genetics
  • Bone Regeneration / genetics
  • Bone Regeneration / physiology*
  • Bone Transplantation / methods
  • Bone Transplantation / physiology
  • Collagen
  • DNA, Complementary
  • Dental Implants*
  • Drug Delivery Systems
  • Female
  • Frontal Bone / metabolism*
  • Gene Expression Regulation / physiology
  • Gene Transfer Techniques
  • Genetic Therapy / methods*
  • Genetic Vectors / administration & dosage
  • Liposomes
  • Osseointegration / genetics
  • Osseointegration / physiology*
  • Osteogenesis / genetics
  • Osteogenesis / physiology
  • Plasmids / administration & dosage
  • Statistics, Nonparametric
  • Sus scrofa
  • Transforming Growth Factor beta / administration & dosage*
  • Transforming Growth Factor beta / genetics
  • Transplantation, Autologous / methods
  • Transplantation, Autologous / physiology

Substances

  • Bone Morphogenetic Protein 2
  • Bone Morphogenetic Proteins
  • DNA, Complementary
  • Dental Implants
  • Liposomes
  • Transforming Growth Factor beta
  • Collagen